Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium

  • Carlo Botrugno
  • , Chiara Crico
  • , Mauro Iori
  • , Oliver Blanck*
  • , Slawomir Blamek
  • , Pieter G. Postema
  • , Aurelio Quesada
  • , Etienne Pruvot
  • , Joost J.C. Verhoeff
  • , Ludovica De Panfilis
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

15 Downloads (Pure)

Abstract

This preliminary ethical appraisal from the STOPSTORM.eu consortium is meant to raise critical points that clinicians administering stereotactic arrhythmia radioablation should consider to meet the highest standards in medical ethics and thus promote quality of life of patients recruited for radiotherapy treatments at a stage in which they experience a significant degree of vulnerability.

Original languageEnglish
Pages (from-to)903-907
Number of pages5
JournalStrahlentherapie und Onkologie
Volume200
Issue number10
Early online date23 Apr 2024
DOIs
Publication statusPublished - Oct 2024

Keywords

  • Bioethics
  • Cardiovascular disease
  • Ethics in research
  • Stereotactic Body Radiotherapy
  • Ventricular tachycardia

Fingerprint

Dive into the research topics of 'Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium'. Together they form a unique fingerprint.

Cite this